Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021
PHIOW
PHIOW was delisted on the 21st of December, 2021.
3 hedge funds and large institutions have $233K invested in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 in 2020 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 1 closing their positions.
5,725% more capital invested
Capital invested by funds: $4K → $233K (+$229K)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
50% more funds holding
Funds holding: 2 → 3 (+1)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$13.1K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$136 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$4K |
| 2 |
Osaic Holdings
Scottsdale,
Arizona
|
-$106 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AFM
1
Anson Funds Management
Dallas,
Texas
| $232K | +$13.1K | +86,299 | New |
|
|
2
Osaic Holdings
Scottsdale,
Arizona
| $1K | -$106 | -700 | -19% |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$4K | -24,591 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | +$136 | +899 | New |
|
PHIOW Hedge Fund Activity: Q4 2020 in Review
3 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) for Q4 2020, worth a combined $233K — up 5,725% from $4K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PHIOW positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Anson Funds Management, opening a new position worth an estimated $13.1K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $4K sold.
- 3 institutional investors held Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 (PHIOW) as of Q4 2020, up from 2 in Q3 2020.
- Funds reported $233K of Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 stock for Q4 2020, up 5,725% quarter-over-quarter.
- 2 funds opened new Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 positions in Q4 2020 and 1 closed out, a net change of +1 holder.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 buyer in Q4 2020 was Anson Funds Management, an estimated $13.1K added.
- The largest Phio Pharmaceuticals Corp. Warrants expiring 12/21/2021 seller in Q4 2020 was Susquehanna International Group, an estimated $4K sold.
Based on aggregated 13F filings for Q4 2020.